
Related to the increase in participants recruited to clinical research, the variety of studies and opportunity to participate have likewise increased.
Dorset County Hospital appeared in the media recently due to the praise received by one of their trial participants. You can read the article here on Wessexfm’s website.
Our local Clinical Research Network (CRN) likewise published the good news, and signpost the Research Activity League Table, where you can see how much clinical research is happening, where, in what types of trusts, and involving how many patients.
Within the CRN’s article, Dr Zoe Sheppard, Head of Research at DCH, and Rebecca McKay, Chief Operating Officer of the Wessex CRN signpost the fantastic recruitment achieved by DCH over the last year, and the growing opportunity for people to participate in research, in turn improving care and treatments.
As always, if you’re interesting in running your own research in the NHS, get in touch with Research Ethics.
Research Active Dorset – delivering research and Innovation in Dorset’s Integrated Care Systems
Dorset physio shares first experience as Principal Investigator on NIHR funded study










BU students’ publishing success
BU presentation at the University of Bristol
Art and Design: History, Practice and Theory academics – would you like to get more involved in preparing our next REF submission?
UKCGE Recognised Research Supervision Programme: Final Deadline Reminder
The significance of Rights and Protocols in Disaster Response
Celebrate World Wellbeing Week This June
Horizon Europe Cluster 3 (Civil Security for Society) 2026 Calls Now Open
MSCA Doctoral Networks 2026 Call Information Webinar
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease